Crop Life ScienceNSE:CLSL -0.54%64 Net Current Asset Value is ₹21.92 as of Mar. 2026, which is 100% below its 10-year median of 1.98. GuruFocus rates NSE:CLSL with a GF Score™ of 64/100 and a GF Value™ of ₹55.12 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 162 Agriculture companies, Crop Life Science ranks better than 67.9% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Crop Life Science's net current asset value per share for the quarter that ended in Mar. 2026 was ₹21.92.
The historical rank and industry rank for Crop Life Science's Net Current Asset Value or its related term are showing as below:
NSE:CLSL'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.36 Med: 1.98 Max: 2.31
Current: 2.1
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Crop Life Science was 2.31. The lowest was 1.36. And the median was 1.98.
NSE:CLSL's Price-to-Net-Current-Asset-Value is ranked better than 67.9% of 162
companies
in the Agriculture industry
Industry Median: 3.52
vs NSE:CLSL: 2.10
Crop Life Science (NSE:CLSL) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Crop Life Science Net Current Asset Value Related Terms
Crop Life Science Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:CLSL vs CTVA, CF, MOS: Net Current Asset Value Comparison
For the Agricultural Inputs subindustry, Crop Life Science's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science Price-to-Net-Current-Asset-Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Crop Life Science's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹21.92 mean?
Crop Life Science (NSE:CLSL) has a Net Current Asset Value of ₹21.92 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Crop Life Science and its competitors. This is 1007% above median its historical median of 1.98. Over the past decade, Crop Life Science's Net Current Asset Value has ranged from 1.36 to 2.31. According to the industry distribution chart, Crop Life Science ranks #52 out of 162 companies in the Agriculture industry, placing it in the top 32.1%.
Is Crop Life Science's Net Current Asset Value too high?
Crop Life Science's current Net Current Asset Value of ₹21.92 is 1007% above median its 10-year median of 1.98. Over the past 10 years, this metric has ranged from a low of 1.36 to a high of 2.31. Based on the distribution chart, Crop Life Science ranks #52 out of 162 companies in the Agriculture industry, which is above the industry midpoint. Overall, Crop Life Science has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Net Current Asset Value compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #52 out of 162 companies for Net Current Asset Value. This puts Crop Life Science in the upper half of its industry. The industry median Net Current Asset Value is 3.52. Historically, Crop Life Science's own Net Current Asset Value has ranged from 1.36 to 2.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for an Agriculture company?
The median Net Current Asset Value among Agriculture companies is 3.52, based on 162 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median Net Current Asset Value is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current Net Current Asset Value is ₹21.92, which is 1007% above median its own 10-year median of 1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹55.12, compared to a current price of ₹46.00 — trading 16.5% below its estimated fair value. The current Net Current Asset Value is ₹21.92, which is 1007% above median its 10-year median of 1.98. Crop Life Science's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Net Current Asset Value is ₹21.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be undervalued.
The current stock price of ₹46.00 is trading 16.5% below its estimated GF Value™ of ₹55.12.
GuruFocus considers Crop Life Science to be Modestly Undervalued.
Key valuation signals for NSE:CLSL:
Net Current Asset Value: ₹21.92 (1007% above median its 10-year median of 1.98)
GF Value™: ₹55.12 vs. price of ₹46.00 (16.5% below fair value)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
64GF Score
Get the complete analysis for NSE:CLSL
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
